Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis. [electronic resource]
Producer: 20160803Description: 12297 p. digitalISSN:- 2045-2322
- Animals
- Cell Line, Tumor
- DNA, Antisense -- administration & dosage
- Disease Models, Animal
- Gold -- chemistry
- Humans
- Metal Nanoparticles -- chemistry
- Mice
- Mice, Nude
- Neoplasms -- diagnosis
- Proto-Oncogene Proteins p21(ras) -- genetics
- Spectroscopy, Fourier Transform Infrared
- Theranostic Nanomedicine
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.